NEW YORK (GenomeWeb) – Two commercially available sequencing platforms are capable of producing drug-resistance profiles for Mycobacterium tuberculosis, according to a new Genome Medicine study.

There has been a rise in recent years in the incidence of multidrug-resistant and extensively drug-resistant tuberculosis, but gauging the resistance profile of M. tuberculosis can be a slow and expensive process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A company hopes to capture the genetic diversity in India to power tailored therapeutics, BBC News reports.

Researchers tie variants in seven genes to insomnia risk, Live Science reports.

The US Environmental Protection Agency has approved an RNAi-based insecticide, according to the Atlantic.

In PLOS this week: locus near OAS1 linked to Sjogren's syndrome, rotavirus reassortment events uncovered by sequencing, and more.

Jun
28
Sponsored by
Agilent Technologies

This webinar will address the advantages and challenges of using array-based comparative genomic hybridization (array-CGH) in the investigation of developmental disorders.

Jun
29
Sponsored by
PerkinElmer

This online seminar will provide an overview of current standardization efforts in genomics, epigenomics, and metagenomics, with a focus on practical implementation considerations for researchers and labs.

Jul
20
Sponsored by
NuGEN

This webinar describes the characterization of gene fusions across distinct subtypes of melanoma.